Drug coated balloon supported Supera stent versus Supera stent in intermediate and long-segment lesions of the superficial femoral artery: 2-year results of the RAPID trial.

CONCLUSIONS: The 2-year results in the current trial of a primary Supera stenting strategy are consistent with other trials reporting on treatment of intermediate and long SFA lesions. A DCB supported Supera stent strategy did not improve patency rate compared to a Supera stent only strategy.
PMID: 31603295 [PubMed - as supplied by publisher]

Source: The Journal of Cardiovascular Surgery - October 8, 2019 Category: Cardiovascular & Thoracic Surgery Authors: de Boer SW, de Vries JP, Werson DA, Fioole B, Vroegindeweij D, Vos JA, van den Heuvel D, RAPID trial investigators Tags: J Cardiovasc Surg (Torino) Source Type: research